In this study, we also evaluated the diagnostic criteria for predicting LC risk in LC patients compared to HRR groups based on sensitivity, specificity and ROC for serum CEA, Cyfra21-1 and IL-8. This evidence concerns the gene CEACAM5 and laryngotracheoesophageal cleft.